Stock listing
OCD1 Stock Price, News, Filings & Events — Niagen Bioscience, Inc.
Selected listing: OCD1 · GETTEX · EUR · DE
This page tracks Niagen Bioscience, Inc.'s OCD1:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCD1:GETTEX. OCD1:GETTEX is the stock-level entry point for investors researching Niagen Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Niagen Bioscience, Inc. (ticker: NAGE) is a publicly traded company based in America, with a market capitalization of approximately $261.2 million. The company focuses on innovative bioscience solutions. Investors can find detailed information about its operations and performance on its public company page.
- Ticker
- OCD1:GETTEX
- Asset type
- Stock
- Market cap
- $246.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- GETTEX
- Currency
- EUR
Niagen Bioscience, Inc. OCD1:GETTEX stock context
This page tracks Niagen Bioscience, Inc.'s OCD1:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCD1:GETTEX. OCD1:GETTEX is the stock-level entry point for investors researching Niagen Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Niagen Bioscience, Inc. (ticker: NAGE) is a publicly traded company based in America, with a market capitalization of approximately $261.2 million. The company focuses on innovative bioscience solutions. Investors can find detailed information about its operations and performance on its public company page.
Latest news from Niagen Bioscience, Inc.
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
August 26, 2026
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
August 20, 2026
Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
August 12, 2026
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
August 3, 2026
Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR...
July 28, 2026
Niagen Bioscience, Inc. earnings calls
Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Niagen Bioscience, Inc. (NAGE) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Niagen Bioscience, Inc. (NAGE) Q4 2025 Earnings Call
March 4, 2026 · Replay with transcript and chapters
Niagen Bioscience, Inc. (NAGE) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Niagen Bioscience, Inc. (NAGE) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Niagen Bioscience, Inc. (NAGE) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Niagen Bioscience, Inc.
Niagen Bioscience, Inc. investor report
Review AI stock analysis and investor report context for OCD1:GETTEX.
Niagen Bioscience, Inc. company profile
View the public company page for Niagen Bioscience, Inc. on 6ix.
Niagen Bioscience, Inc. news
Read company news and market updates connected to Niagen Bioscience, Inc..
Niagen Bioscience, Inc. investor events
Find investor webinars, events, and replay context for Niagen Bioscience, Inc..
Alternate listings
NAGE:NASDAQ
US · USD
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
A2AG5N:LSX
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
NAGE:BOATS
US · USD
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
A2AG5N:LS
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
OCD1:FWB
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
OCD1:DUS
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
OCD1:HAM
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
OCD1:MUN
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
OCD1:SWB
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.
OCD1:TRADEGATE
DE · EUR
Alternate listing for Niagen Bioscience, Inc.; the primary context on this page is OCD1:GETTEX.